Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
65.69
195.3119
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Eyebright Medical Technology Beijing Co Ltd stock under the Base Case scenario is 77.17 CNY. Compared to the current market price of 87.24 CNY, Eyebright Medical Technology Beijing Co Ltd is Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Eyebright Medical Technology Beijing Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Eyebright Medical Technology Beijing Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Eyebright Medical Technology Beijing Co Ltd
Balance Sheet Decomposition
Eyebright Medical Technology Beijing Co Ltd
Current Assets | 1B |
Cash & Short-Term Investments | 551.9m |
Receivables | 244.1m |
Other Current Assets | 226.9m |
Non-Current Assets | 2B |
Long-Term Investments | 154.4m |
PP&E | 1.4B |
Intangibles | 386.4m |
Other Non-Current Assets | 91.8m |
Current Liabilities | 377.8m |
Accounts Payable | 49m |
Accrued Liabilities | 51.3m |
Short-Term Debt | 25.5m |
Other Current Liabilities | 251.9m |
Non-Current Liabilities | 554.4m |
Long-Term Debt | 272.4m |
Other Non-Current Liabilities | 282m |
Earnings Waterfall
Eyebright Medical Technology Beijing Co Ltd
Revenue
|
1.1B
CNY
|
Cost of Revenue
|
-297.6m
CNY
|
Gross Profit
|
774.2m
CNY
|
Operating Expenses
|
-421.7m
CNY
|
Operating Income
|
352.5m
CNY
|
Other Expenses
|
-24.1m
CNY
|
Net Income
|
328.5m
CNY
|
Free Cash Flow Analysis
Eyebright Medical Technology Beijing Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Eyebright Medical Technology Beijing Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Eyebright Medical Technology Beijing Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Eyebright Medical Technology Beijing Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Eyebright Medical Technology Beijing Co Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Eyebright Medical Technology Beijing Co Ltd
According to Wall Street analysts, the average 1-year price target for Eyebright Medical Technology Beijing Co Ltd is 118.11 CNY with a low forecast of 97.36 CNY and a high forecast of 136.5 CNY.
Dividends
Current shareholder yield for Eyebright Medical Technology Beijing Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. The company is headquartered in Beijing, Beijing and currently employs 579 full-time employees. The company went IPO on 2020-07-29. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The firm conducts its businesses in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Eyebright Medical Technology Beijing Co Ltd stock under the Base Case scenario is 77.17 CNY.
Compared to the current market price of 87.24 CNY, Eyebright Medical Technology Beijing Co Ltd is Overvalued by 12%.